Physician profile

Matthew W Lewis

Orthopaedic Surgery · Vancleave, MS

NPI 1003043506

$1,025.61

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

See the full distribution for Orthopaedic Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$391.95
Travel and Lodging$202.81

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Alon Medical Technology $263.03 2023
Depuy Synthes Sales INC. $231.43 2021-2023 Na
Smith+Nephew, INC. $206.25 2021
Stryker Corporation $202.81 2023 Mako
Horizon Therapeutics Plc $85.11 2019-2021
Innovation Technologies INC $13.50 2023 Irrisept
Ferring Pharmaceuticals INC. $13.18 2019
Electronic Waveform Lab, INC. $10.30 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Matthew W Lewis

$1,025.61

in general payments reported 2019-2025

Years
2019-2023
Top company
Alon Medical Technology

https://glasscript.com/doctor/1217339/matthew-w-lewis

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.